Atlas Trials

To Evaluate Effectiveness of Aclidinium Bromide/Formoterol Fumarate Dihydrate in Chronic Obstructive Pulmonary Disease

Clinical trial NCT03181880 · WITHDRAWN

Trial details

NCT number
NCT03181880
Sponsor
AstraZeneca
Status
WITHDRAWN
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Obstructive Pulmonary Disease
Start date
2017-12-04
Primary completion
2018-12-03
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.